Literature DB >> 35693991

Factors associated with atrial fibrillation in Japanese patients with type 2 diabetes mellitus: a cross-sectional study.

Natsuki Honda1,2, Akinobu Ochi1, Sadahiko Uchimoto2, Yoshinori Kakutani1, Yuko Yamazaki1, Tomoaki Morioka1, Tetsuo Shoji3,4, Masaaki Inaba1, Masanori Emoto1.   

Abstract

Aims: Atrial fibrillation (AF) increases cardiovascular complications and mortality in patients with diabetes. Diabetes is a risk factor for AF; however, risk factors for AF among patients with type 2 diabetes (T2D) remain unknown, especially among Asian people. We clarified the prevalence of AF, regardless of type (i.e., paroxysmal, persistent, or permanent) in Japanese patients with T2D and clarified factors associated with AF.
Methods: This cross-sectional study was conducted at Fujiidera Municipal Hospital (Osaka, Japan). Patients with T2D (n = 899: 518 men and 381 women with a mean age ± SD of 69.0 ± 12.1 years) were included. Their electrocardiographs were checked during routine examinations between January 2017 and January 2018. A diagnosis of AF was determined from single time-point standard 12-lead electrocardiographic findings. We analyzed clinical parameters (e.g., age, sex, diabetes duration, glycated hemoglobin, body mass index, estimated glomerular filtration rate, albuminuria or proteinuria, use of biguanide, and presence of hypertension) between patients with and without AF.
Results: The prevalence of AF among patients with T2D was 5.9%; it became higher as age increased and tended to be higher in men than in women. The prevalence became higher as albuminuria or proteinuria progressed and as the eGFR decreased. Multiple logistic regression analyses revealed that older age, male sex, and reduced eGFR were independently and significantly associated with the coexistence of AF. However, multiple logistic regression analysis revealed no significant relationships between AF and the presence of albuminuria or proteinuria. Conclusions: Older age, male sex, and reduced eGFR were associated with AF in Japanese patients with T2D. Supplementary Information: The online version contains supplementary material available at 10.1007/s13340-021-00563-w. © The Japan Diabetes Society 2021.

Entities:  

Keywords:  Atrial fibrillation; Glomerular filtration rate; Japan; Prevalence; Type 2 diabetes

Year:  2022        PMID: 35693991      PMCID: PMC9174394          DOI: 10.1007/s13340-021-00563-w

Source DB:  PubMed          Journal:  Diabetol Int        ISSN: 2190-1678


  35 in total

Review 1.  Diabetes mellitus and atrial remodeling: mechanisms and potential upstream therapies.

Authors:  Qitong Zhang; Tong Liu; Chee Y Ng; Guangping Li
Journal:  Cardiovasc Ther       Date:  2014-10       Impact factor: 3.023

2.  Chapter 1: Definition and classification of CKD.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2013-01

3.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Authors:  B F Gage; A D Waterman; W Shannon; M Boechler; M W Rich; M J Radford
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

4.  Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease.

Authors:  Mohammad-Reza Movahed; Mehrtash Hashemzadeh; M Mazen Jamal
Journal:  Int J Cardiol       Date:  2005-12-07       Impact factor: 4.164

5.  Diabetes mellitus, glycemic control, and risk of atrial fibrillation.

Authors:  Sascha Dublin; Nicole L Glazer; Nicholas L Smith; Bruce M Psaty; Thomas Lumley; Kerri L Wiggins; Richard L Page; Susan R Heckbert
Journal:  J Gen Intern Med       Date:  2010-04-20       Impact factor: 5.128

6.  Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination.

Authors:  Hiroshi Inoue; Akira Fujiki; Hideki Origasa; Satoshi Ogawa; Ken Okumura; Isao Kubota; Yoshifusa Aizawa; Takeshi Yamashita; Hirotsugu Atarashi; Minoru Horie; Tohru Ohe; Yoshinori Doi; Akihiko Shimizu; Akiko Chishaki; Tetsunori Saikawa; Katsusuke Yano; Akira Kitabatake; Hideo Mitamura; Itsuo Kodama; Shiro Kamakura
Journal:  Int J Cardiol       Date:  2008-08-08       Impact factor: 4.164

7.  Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.

Authors:  Sumeet S Chugh; Rasmus Havmoeller; Kumar Narayanan; David Singh; Michiel Rienstra; Emelia J Benjamin; Richard F Gillum; Young-Hoon Kim; John H McAnulty; Zhi-Jie Zheng; Mohammad H Forouzanfar; Mohsen Naghavi; George A Mensah; Majid Ezzati; Christopher J L Murray
Journal:  Circulation       Date:  2013-12-17       Impact factor: 29.690

8.  The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study.

Authors:  A D Krahn; J Manfreda; R B Tate; F A Mathewson; T E Cuddy
Journal:  Am J Med       Date:  1995-05       Impact factor: 4.965

Review 9.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690

10.  Atrial Fibrillation and Risk of ESRD in Adults with CKD.

Authors:  Nisha Bansal; Dawei Xie; Kelvin Tao; Jing Chen; Rajat Deo; Edward Horwitz; Chi-Yuan Hsu; Radha Krishna Kallem; Martin G Keane; Claudia M Lora; Dominic Raj; Elsayed Z Soliman; Louise Strauss; Myles Wolf; Alan S Go
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-12       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.